Search

Your search keyword '"C. De la Pinta Alonso"' showing total 14 results
Start Over Author "C. De la Pinta Alonso"
14 results on '"C. De la Pinta Alonso"'

1. 1982P Fibroblasts-derived matrices confer resistance to oxaliplatin and cetuximab in a snail-dependent way in CRC

Author

Carmen Peña, E. Romio de las Heras, Federico Longo, C. De la Pinta Alonso, José Barquín, Meléndez Rodríguez, C. Perna, C. Galindo Pumariño, J. Villalón López, A. Carrato Mena, and P. Reguera Puertas

Subjects
Oncology, Cetuximab, biology, business.industry, biology.animal, medicine, Cancer research, Hematology, Snail, business, medicine.drug, Oxaliplatin
Published
2020
Full Text
View/download PDF

2. EP-1213 Prediction of new brain metastases after radiosurgery: validation of two nomograms in our serie

Author

S. Sancho, C. Vallejo, S. Barrio, E. Fernández-Lizarbe, R. Hernanz, M. Martín Martín, María Dolores Torres, M. Martin, C. De la Pinta Alonso, and A.B. Capúz

Subjects
medicine.medical_specialty, Oncology, business.industry, medicine.medical_treatment, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, Radiology, Nomogram, business, Radiosurgery
Published
2019
Full Text
View/download PDF

3. EP-1411 What is the best imaging study to contouring liver metastases in SBRT?

Author

C. De la Pinta Alonso, J.D. García, D. Sevillano, R. García, A. Martínez-Lorca, M. Martín, E. Fernández-Lizarbe, J.A. Domínguez, R. Hernanz, T. Muñóz, and S. Sancho

Subjects
Contouring, medicine.medical_specialty, Oncology, business.industry, Medicine, Radiology, Nuclear Medicine and imaging, Imaging study, Hematology, Radiology, business
Published
2019
Full Text
View/download PDF

4. PV-0575 Is diaphragm dome or bone fusion adequate to IGRT in liver-SBRT compare to fiducial markers?

Author

S. Barrio, E. Fernández-Lizarbe, R. Colmenares, M.T. Martín, V. Pino, D. Sevillano, S. Sancho, C. Vallejo, C. De la Pinta Alonso, and J.A. Rojo

Subjects
Oncology, business.industry, Bone fusion, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, Diaphragm dome, Nuclear medicine, business, Fiducial marker, Image-guided radiation therapy
Published
2019
Full Text
View/download PDF

6. EP-1333: Predictive Factors of Recurrence after Mastectomy for Ductal Carcinoma in situ

Author

E. Fernández-Lizarbe, C. De la Pinta Alonso, B. Pérez Mies, R. Hernanz de Lucas, A. Montero Luis, M. Martín Sánchez, A. Muriel, and S. Sancho García

Subjects
In situ, medicine.medical_specialty, Oncology, business.industry, medicine.medical_treatment, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Radiology, Ductal carcinoma, business, Mastectomy
Published
2018
Full Text
View/download PDF

7. EP-1433 GTV contouring in hepatocellular carcinoma: a comparison between two imaging techniques

Author

E. Fernández-Lizarbe, T. Muñoz, C. Vallejo, Jo Garcia, M. Martín Sánchez, J.A. Domínguez, R. Hernanz, S. Sancho, R. García, C. De la Pinta Alonso, D. Sevillano, and M. Martín Martín

Subjects
Contouring, Oncology, business.industry, Hepatocellular carcinoma, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, Nuclear medicine, business, medicine.disease
Published
2019
Full Text
View/download PDF

8. EP-1410 PET compared to CT in target delineation for SBRT of pancreas adenocarcinoma

Author

C. De la Pinta Alonso, J.D. García, D. Sevillano, A. Martínez-Lorca, R. García, M. Martín, R. Hernanz, E. Fernández-Lizarbe, T. Muñóz, J.A. Domínguez, J.F. Crespo, C. Vallejo, A. Hervás, F. López, and S. Sancho

Subjects
Pancreas adenocarcinoma, Oncology, business.industry, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, Nuclear medicine, business
Published
2019
Full Text
View/download PDF

10. EP-1295: Validation of the MSKCC-nomogram in the prediction of recurrence risk after treatment in DCIS

Author

R. Hernanz de Lucas, E. Fernández-Lizarbe, A. Montero Luis, C. De la Pinta Alonso, M. Martín Sánchez, B. Pérez, A. Muriel, S. Sancho García, and T. Muñoz Miguelañez

Subjects
Oncology, medicine.medical_specialty, business.industry, Internal medicine, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, Nomogram, business, After treatment, Recurrence risk
Published
2018
Full Text
View/download PDF

11. EP-1702: Stereotactic body radiotherapy for oligometastatic and oligoprogression patients

Author

A. Hervás Morón, F. Lopez Campos, E. Fernández-Lizarbe, T. Muñóz Migueláez, M. Martín Sánchez, M. Martín Martín, C. De la Pinta Alonso, R. Hernanz de Lucas, C. Vallejo Ocaña, S. Sancho García, and J.A. Dominguez Rullan

Subjects
medicine.medical_specialty, Oncology, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Radiology, Stereotactic body radiotherapy
Published
2018
Full Text
View/download PDF

12. EP-1654: Evaluation of tolerability in combined treatment with immune inhibitors and palliative radiotherapy

Author

C. Vallejo Ocaña, S. Sancho García, F. Lopez Campos, M. Martín Martín, T. Muñoz Miguelañez, M. Martín Sánchez, J.A. Domínguez-Rullán, P. Barrionuevo, C. De la Pinta Alonso, A. Hervás Morón, R. Hernanz de Lucas, and E. Fernández-Lizarbe

Subjects
Oncology, medicine.medical_specialty, Combined treatment, Immune system, Tolerability, Palliative radiotherapy, business.industry, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Hematology, business
Published
2018
Full Text
View/download PDF

14. Radiation-induced liver disease in the era of SBRT: a review.

Author

De La Pinta Alonso C

Subjects
Biomarkers analysis, Biomarkers blood, Diagnosis, Differential, Humans, Liver Diseases diagnosis, Liver Diseases etiology, Liver Diseases physiopathology, Radiation Injuries diagnosis, Radiation Injuries etiology, Radiation Injuries physiopathology, Risk Factors, Liver radiation effects, Radiosurgery adverse effects
Abstract

Introduction: Stereotactic Body Radiotherapy (SBRT) in liver tumors allows ablative radiation doses in tumors preserving the liver tissue. However, liver is a parallel organ allowing high doses in a small region to preserve its function. If this is not possible, radio-induced liver toxicity is produced. Radio-induced liver toxicity or radio-induced liver disease (RILD) is the most serious toxicity in liver radiotherapy., Areas Covered: In this review, we analyzed published literature on PubMed and MEDLINE. We included papers in English language with information about RILD characteristics, diagnostic, risk factors, pathophysiology, and treatment. All citations were evaluated for relevant content and validation., Expert Opinion: The study of RILD is fundamental before the implementation of liver SBRT. Radio-induced liver toxicity is a complication that can be fatal for patients. This is a diagnosis of exclusion and it is essential that experts in the treatment of hepatic SBRT know about it and anticipate its development. The study and development of molecular or imaging biomarkers could be key in their diagnosis and prevention.

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results